Guacetisal
Chemical compound
- N02BA14 (WHO)
- 2-Methoxyphenyl 2-acetoxybenzoate
- 55482-89-8
- 68749
- 61994
- T6EKB9V2O2
- ChEMBL2105097
- DTXSID40204060
- Interactive image
- O=C(Oc1ccccc1C(=O)Oc2ccccc2OC)C
InChI
- InChI=1S/C16H14O5/c1-11(17)20-13-8-4-3-7-12(13)16(18)21-15-10-6-5-9-14(15)19-2/h3-10H,1-2H3
- Key:HSJFYRYGGKLQBT-UHFFFAOYSA-N
Guacetisal is a drug that has been used to treat inflammatory respiratory diseases.[1] Chemically, it is an ester resulting from the combination of aspirin and guaiacol.[citation needed]
References
- ^ Vizioli A, Zamperini D, Ursaia G (December 1982). "[Clinical trial of guacetisal in aged subjects with inflammatory diseases of the respiratory tract]". La Clinica Terapeutica. 103 (5): 527–33. PMID 6761043.
- v
- t
- e
pyrazolidines
and related substances
- Ampiroxicam
- Droxicam
- Isoxicam
- Lornoxicam
- Meloxicam
- Piroxicam
- Pivoxicam
- Tenoxicam
derivatives (profens)
- Alminoprofen
- Benoxaprofen†
- Carprofen‡
- Dexibuprofen
- Dexketoprofen
- Fenbufen
- Fenoprofen
- Flunoxaprofen
- Flurbiprofen
- Ibuprofen#
- Ibuproxam
- Indoprofen†
- Ketoprofen
- Loxoprofen
- Miroprofen
- Naproxen
- Oxaprozin
- Pelubiprofen
- Piketoprofen
- Pirprofen
- Suprofen
- Tarenflurbil
- Tepoxalin‡
- Tiaprofenic acid
- Vedaprofen‡
- Zaltoprofen
- COX-inhibiting nitric oxide donator: Naproxcinod
acids (fenamates)
(coxibs)
combinations
Key: underline indicates initially developed first-in-class compound of specific group; #WHO-Essential Medicines; †withdrawn drugs; ‡veterinary use.
category
commons
portal
 | This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
